Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Holding GB:AGY?
Track your performance easily

Allergy Therapeutics (AGY) Financial Statements

12 Followers

Allergy Therapeutics Financial Overview

Allergy Therapeutics's market cap is currently ―. The company's EPS TTM is p-0.01; its P/E ratio is -5.37; Allergy Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 20.52M£ 41.38M£ 40.27M£ 48.29M£ 36.96M
Total Assets£ 73.58M£ 91.97M£ 88.09M£ 99.00M£ 86.22M
Total Debt£ 10.53M£ 9.93M£ 11.17M£ 11.99M£ 12.18M
Net Debt£ -9.99M£ -31.45M£ -29.10M£ -36.30M£ -24.78M
Total Liabilities£ 35.18M£ 37.00M£ 39.55M£ 40.27M£ 42.44M
Stockholders Equity£ 38.40M£ 54.97M£ 48.53M£ 58.73M£ 43.78M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Allergy Therapeutics Earnings and Revenue History

Allergy Therapeutics Debt to Assets

Allergy Therapeutics Cash Flow

Allergy Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis